URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Thomas Watson

Concepts (215)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Esophageal Neoplasms
17
2004
75
4.870
Why?
Esophageal Diseases
7
1997
19
3.070
Why?
Esophagectomy
14
1997
33
2.750
Why?
Adenocarcinoma
11
2007
439
2.750
Why?
Barrett Esophagus
9
2004
24
2.710
Why?
Esophagoscopy
9
2005
26
2.620
Why?
Precancerous Conditions
3
2008
38
1.920
Why?
Gastroesophageal Reflux
6
1998
29
1.590
Why?
Esophagus
9
2007
69
1.400
Why?
Digestive System Surgical Procedures
2
2009
23
1.300
Why?
Lymph Nodes
3
2002
206
0.910
Why?
Fundoplication
3
2005
16
0.850
Why?
Trachea
2
2005
68
0.840
Why?
Mediastinum
2
2009
20
0.780
Why?
Bronchoscopy
1
2010
29
0.740
Why?
Stomach
5
1997
72
0.740
Why?
Deglutition
2
2009
17
0.720
Why?
Hernia, Hiatal
4
2009
12
0.690
Why?
Humans
47
1996
36274
0.680
Why?
Neoplasm Recurrence, Local
2
2008
288
0.680
Why?
Catheter Ablation
2
2009
73
0.670
Why?
Treatment Outcome
13
1996
2615
0.640
Why?
Homeodomain Proteins
4
2007
103
0.580
Why?
Robotics
1
2008
76
0.570
Why?
Manometry
4
2005
16
0.550
Why?
Patient Selection
6
1996
212
0.540
Why?
Esophagogastric Junction
1
2005
9
0.520
Why?
Polymethyl Methacrylate
1
2005
20
0.510
Why?
Lung Neoplasms
5
2002
439
0.510
Why?
Lung
2
1996
1159
0.490
Why?
Hydrogen-Ion Concentration
2
2005
566
0.480
Why?
Thoracic Surgery
1
2004
13
0.480
Why?
Male
32
1998
19675
0.470
Why?
Preoperative Care
1
2005
131
0.470
Why?
Bile Acids and Salts
3
2007
22
0.470
Why?
Lymphatic Metastasis
6
2002
142
0.430
Why?
Female
27
1998
19838
0.400
Why?
Jejunum
2
1997
52
0.390
Why?
Aged
21
1998
7269
0.380
Why?
Sensitivity and Specificity
4
2002
905
0.380
Why?
Colon
2
1997
74
0.370
Why?
Esophageal pH Monitoring
2
2009
4
0.370
Why?
Middle Aged
22
1998
9837
0.360
Why?
Surgical Procedures, Minimally Invasive
2
2008
30
0.340
Why?
Diagnostic Techniques, Digestive System
2
2009
6
0.340
Why?
Neoplasm Staging
6
2008
338
0.330
Why?
Radiation-Sensitizing Agents
2
2007
75
0.320
Why?
Carcinoma, Non-Small-Cell Lung
2
2007
72
0.310
Why?
Follow-Up Studies
6
1998
1855
0.310
Why?
Risk Assessment
3
2005
884
0.290
Why?
Mucins
2
2007
27
0.290
Why?
Reconstructive Surgical Procedures
1
1998
83
0.290
Why?
Prognosis
3
2008
1083
0.290
Why?
Aged, 80 and over
11
2002
2529
0.280
Why?
Lung Transplantation
1
1996
12
0.280
Why?
Intestines
2
2007
154
0.270
Why?
Anastomosis, Surgical
3
1998
67
0.270
Why?
Peristalsis
2
2011
4
0.250
Why?
Clinical Trials as Topic
2
2008
671
0.250
Why?
Bronchi
2
1996
86
0.250
Why?
Survival Analysis
4
2008
606
0.240
Why?
Neoplasm Invasiveness
3
2009
155
0.240
Why?
Predictive Value of Tests
3
2009
606
0.230
Why?
Deglutition Disorders
2
1998
21
0.230
Why?
RNA, Messenger
4
2007
1863
0.230
Why?
Postoperative Complications
5
2007
733
0.230
Why?
Severity of Illness Index
3
2005
922
0.220
Why?
Adult
14
1998
11351
0.220
Why?
Emergencies
2
2009
81
0.210
Why?
Nucleosides
1
2012
11
0.210
Why?
Quantum Theory
1
2012
13
0.210
Why?
Deoxycholic Acid
2
2008
8
0.210
Why?
Population Surveillance
2
2009
136
0.200
Why?
Tomography, X-Ray Computed
2
2002
759
0.200
Why?
Electric Impedance
1
2011
18
0.200
Why?
Retrospective Studies
6
1998
2267
0.190
Why?
Esophageal Achalasia
1
2011
3
0.190
Why?
Registries
2
2009
223
0.190
Why?
Endoscopy
1
2011
80
0.190
Why?
Cancer Care Facilities
1
2010
11
0.190
Why?
Endosonography
1
2010
14
0.180
Why?
Stents
1
2011
129
0.180
Why?
Taxoids
1
2010
14
0.180
Why?
Length of Stay
2
2008
287
0.180
Why?
Surgical Procedures, Elective
1
2009
32
0.170
Why?
Lymph Node Excision
1
2010
46
0.170
Why?
Laparoscopy
1
2012
187
0.170
Why?
Carcinoma
1
2011
191
0.170
Why?
Positron-Emission Tomography
1
2009
39
0.170
Why?
Kyphosis
1
2009
9
0.170
Why?
Swine
1
2009
171
0.170
Why?
Respiration Disorders
1
2009
5
0.170
Why?
Patient Admission
1
2009
85
0.170
Why?
Blood Gas Monitoring, Transcutaneous
1
2009
10
0.170
Why?
Parathyroid Neoplasms
1
2009
12
0.170
Why?
Mediastinal Neoplasms
1
2009
21
0.160
Why?
Receptors, Notch
1
2009
59
0.160
Why?
Models, Animal
1
2009
138
0.160
Why?
Diffusion of Innovation
1
2008
23
0.160
Why?
Diagnosis, Differential
2
2004
874
0.160
Why?
Forecasting
1
2008
177
0.150
Why?
Prevalence
4
2009
562
0.150
Why?
Esophageal Stenosis
1
2007
12
0.150
Why?
Receptor, Epidermal Growth Factor
1
2008
93
0.150
Why?
Anoxia
1
2009
159
0.150
Why?
Antineoplastic Agents, Phytogenic
1
2007
40
0.150
Why?
Paclitaxel
1
2007
58
0.150
Why?
Biopsy, Needle
2
2003
145
0.150
Why?
Gastrectomy
1
2007
10
0.140
Why?
DNA
1
2012
845
0.140
Why?
Quality of Life
1
2011
502
0.140
Why?
Equipment Design
1
2008
248
0.140
Why?
Epithelial Cells
1
2008
327
0.130
Why?
Adolescent
5
1996
4766
0.130
Why?
Mediastinal Emphysema
1
2005
9
0.130
Why?
Injections, Intralesional
1
2005
13
0.130
Why?
Gastric Acidity Determination
1
2005
6
0.130
Why?
Incidence
1
2008
685
0.130
Why?
Young Adult
4
2009
1059
0.120
Why?
Monitoring, Physiologic
1
2005
100
0.120
Why?
Wounds, Nonpenetrating
1
2005
69
0.120
Why?
Evaluation Studies as Topic
1
2005
245
0.120
Why?
Pneumothorax
1
2004
23
0.120
Why?
Germinoma
1
2004
3
0.120
Why?
Hypertension, Pulmonary
1
2004
29
0.120
Why?
Certification
1
2004
39
0.120
Why?
Mesothelioma
1
2004
30
0.120
Why?
Pulmonary Emphysema
1
2004
33
0.120
Why?
Testicular Neoplasms
1
2004
55
0.110
Why?
Logistic Models
3
2010
611
0.110
Why?
Carcinoma, Squamous Cell
3
2009
236
0.110
Why?
Randomized Controlled Trials as Topic
1
2005
411
0.110
Why?
Tracheoesophageal Fistula
1
2002
6
0.100
Why?
Tracheostomy
1
2002
19
0.100
Why?
Surgical Flaps
1
2002
114
0.090
Why?
Signal Transduction
1
2009
1567
0.090
Why?
Kaplan-Meier Estimate
2
2010
222
0.090
Why?
Odds Ratio
2
2010
315
0.080
Why?
Endoscopy, Digestive System
1
1998
11
0.080
Why?
Child
2
1996
4155
0.080
Why?
Gene Expression Regulation
3
2007
888
0.080
Why?
Vagotomy
1
1997
11
0.080
Why?
Survival Rate
2
2009
618
0.070
Why?
Mucin-2
2
2007
5
0.070
Why?
Cell Line, Tumor
2
2009
575
0.070
Why?
Pneumonectomy
1
1996
14
0.070
Why?
Physical Fitness
1
1996
24
0.070
Why?
Cadaver
1
1996
86
0.070
Why?
Immunosuppression
1
1996
64
0.070
Why?
Tissue Donors
1
1996
69
0.070
Why?
New York
2
2009
1305
0.070
Why?
Cystic Fibrosis
1
1996
58
0.060
Why?
Graft Rejection
1
1996
143
0.060
Why?
Living Donors
1
1996
84
0.060
Why?
Tumor Cells, Cultured
2
2007
881
0.060
Why?
Reoperation
2
2002
183
0.060
Why?
Statistics, Nonparametric
2
2002
262
0.060
Why?
Clavicle
2
2002
19
0.050
Why?
Animals
1
2009
16093
0.050
Why?
Cell Line
2
2007
1585
0.050
Why?
Quality Improvement
1
2012
21
0.050
Why?
Neoplasm Grading
1
2011
8
0.050
Why?
Esophageal Sphincter, Lower
1
2011
2
0.050
Why?
Spasm
1
2011
7
0.050
Why?
Cell Differentiation
2
2007
1093
0.050
Why?
Infant, Newborn
1
1996
1844
0.050
Why?
Preoperative Period
1
2010
5
0.050
Why?
Tumor Stem Cell Assay
1
2010
24
0.050
Why?
SEER Program
1
2010
53
0.050
Why?
Vascular Neoplasms
1
2010
5
0.050
Why?
Dose Fractionation
1
2010
60
0.050
Why?
Granulocyte Colony-Stimulating Factor
1
2010
44
0.050
Why?
Prospective Studies
2
2002
1689
0.040
Why?
Mucous Membrane
1
2010
37
0.040
Why?
Remission Induction
1
2010
161
0.040
Why?
Translational Medical Research
1
2010
38
0.040
Why?
Cisplatin
1
2010
95
0.040
Why?
Child, Preschool
1
1996
2660
0.040
Why?
Dipeptides
1
2009
16
0.040
Why?
Databases, Factual
1
2010
156
0.040
Why?
Confidence Intervals
1
2010
165
0.040
Why?
Drug Administration Schedule
1
2010
366
0.040
Why?
Bone Diseases, Metabolic
1
2009
20
0.040
Why?
Hyperparathyroidism
1
2009
24
0.040
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2009
82
0.040
Why?
Referral and Consultation
1
2010
196
0.040
Why?
Pilot Projects
1
2010
442
0.040
Why?
Combined Modality Therapy
1
2010
486
0.040
Why?
Spinal Fractures
1
2009
35
0.040
Why?
World Health
1
2009
63
0.040
Why?
Sex Factors
1
2010
597
0.040
Why?
Cell Culture Techniques
1
2008
92
0.040
Why?
Photochemotherapy
1
2009
111
0.040
Why?
Biopsy
1
2009
362
0.040
Why?
Reference Values
1
2009
439
0.040
Why?
Recombinant Proteins
1
2010
723
0.040
Why?
Lymphocytes
1
2009
291
0.040
Why?
Ligands
1
2008
288
0.040
Why?
Analysis of Variance
1
2010
736
0.040
Why?
Cohort Studies
1
2011
969
0.040
Why?
Anastomosis, Roux-en-Y
1
2007
12
0.040
Why?
Catheterization
1
2007
125
0.040
Why?
Transcriptional Activation
1
2008
285
0.030
Why?
Treatment Failure
1
2007
128
0.030
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
429
0.030
Why?
Phosphorylation
1
2008
774
0.030
Why?
Chi-Square Distribution
1
2007
344
0.030
Why?
Reproducibility of Results
1
2009
877
0.030
Why?
Immunohistochemistry
1
2009
1064
0.030
Why?
Thoracostomy
1
2004
3
0.030
Why?
Pulmonary Artery
1
2004
86
0.030
Why?
United States
1
2010
2688
0.030
Why?
Risk Factors
1
2009
2345
0.030
Why?
Respiratory Distress Syndrome, Adult
1
2002
75
0.020
Why?
Respiration, Artificial
1
2002
174
0.020
Why?

Visualizations


Watson's Networks

Same Department